Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Protocol for spatially resolved pathology scores using optimal transport on spatial transcriptomics data. [PDF]
Rahman MN +3 more
europepmc +1 more source
APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis. [PDF]
Hatano Y +5 more
europepmc +1 more source
Universal and transferable attacks on pathology foundation models using microscopic perturbations. [PDF]
Wang Y +5 more
europepmc +1 more source
Educational Frameworks for Diagnostic Decision-Making in AI-Enhanced Head and Neck Pathology. [PDF]
Tavares T +4 more
europepmc +1 more source
Cerebellar histomorphometry for age determination of puppies in veterinary forensic pathology
Ressel L, Verin R, Bianco C, Forlani A
core +1 more source
Erratum: WITHDRAWAL - Administrative Duplicate Publication: Expanding the Diagnostic Lens: Mast Cell Activation Syndromes and the Hidden Spectrum of Angioedema Associated Mortality in COVID-19. [PDF]
europepmc +1 more source

